IP Library Granted Patent US 11,186,863
Granted Patent B2
US 11,186,863 · App. 17/150,079 · Granted Nov 30, 2021

Methods, systems, and compositions for counting nucleic acid molecules

Inventors: Matthew Sekedat (Ann Arbor, MI); Jeffrey Buis (Ann Arbor, MI); Ronald David Beaubien, Jr. (Jackson, MI); Sharat Singh (Rancho Santa Fe, CA); Jeff Perry (Ann Arbor, MI); Steven Lockton (San Diego, CA); Chandni Jain (San Diego, CA); Natalie Mae Jameson-Kiesling (San Diego, CA)
Assignee: Progenity, Inc.
C12Q1/6837C12Q1/6853
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,186,863
App. No.
17/150,079
Granted
Nov 30, 2021
Kind
B2
Abstract

Compositions and methods, systems, and kits for detecting and quantifying variations in numbers of molecules, particularly variations in gene dosage, e.g., due to gene duplication, or to variations from the normal euploid complement of chromosomes, e.g., trisomy of one or more chromosomes that are normally found in diploid pairs, without digital sequencing.

Claims (31)

1. A method for nucleic acid molecule analysis, comprising:

a) providing a plurality of molecular inversion probes (MIPs) and a sample of nucleic acid molecules;

b) hybridizing MIPs of the plurality of MIPs to the nucleic acid molecules to generate hybridized MIPs;

c) in a reaction mixture, circularizing hybridized MIPs to form a plurality of circularized nucleic acid probes;

d) treating the reaction mixture with more than one exonuclease, wherein circularized nucleic acid probes are not a substrate for the more than one exonucleases;

e) forming a plurality of complexes comprising a plurality of primers hybridized to a plurality of circularized nucleic acid probes from the reaction mixture following d), wherein the plurality of primers is bound to a solid support;

f) extending the plurality of primers in the plurality of complexes in an amplification reaction to form a plurality of amplification products immobilized to the solid support;

g) in a presence of a detergent, hybridizing a set of labeled probes to the plurality of amplification products to generate a plurality of amplification products comprising hybridized labeled probes, wherein the set of labeled probes comprises five or more different labels; and

h) using imaging to count the plurality of amplification products comprising hybridized labeled probes based on detecting the five or more different labels.

2. The method of claim 1 , wherein the more than one exonucleases comprise Rec Jf.

3. The method of claim 1 , wherein the more than one exonucleases comprise Exo VII.

4. The method of claim 1 , wherein the more than one exonucleases comprise Exo I.

5. The method of claim 4 , wherein the more than one exonucleases comprise Thermolabile Exo I.

6. The method of claim 1 , wherein the more than one exonucleases comprise Rec Jf, Exo VII, and Exo I.

7. The method of claim 1 , wherein the more than one exonucleases comprise Rec Jf, Exo VII, and Thermolabile Exo I.

8. The method of claim 1 , further comprising, between d) and e), inactivating the more than one exonucleases.

9. The method of claim 8 , wherein the inactivating comprises heat-inactivating.

10. The method of claim 1 , wherein the solid support comprises tannic acid.

11. The method of claim 1 , wherein the solid support comprises acrylic acid.

12. The method of claim 1 , wherein the solid support comprises a homopolymeric coating.

13. The method of claim 1 , wherein the plurality of primers is bound to the solid support by a 5′ terminal amine modification.

14. The method of claim 1 , wherein the plurality of primers is covalently bound to the solid support.

15. The method of claim 1 , wherein the solid support comprises glass.

16. The method of claim 1 , wherein the solid support comprises an assay plate.

17. The method of claim 16 , wherein the assay plate is a multi-well assay plate.

18. The method of claim 1 , wherein in f) the plurality of amplification products immobilized to the solid support are in a solution comprising a crowding agent.

19. The method of claim 18 , wherein the crowding agent comprises polyethylene glycol (PEG).

20. The method of claim 19 , wherein the PEG has an average molecular weight between 200 and 8000.

21. The method of claim 19 , wherein the PEG is at a concentration of at least 12%.

22. The method of claim 1 , wherein the plurality of primers are bound to the solid support in an irregular dispersal.

23. The method of claim 1 , wherein the five or more different labels comprise five or more different fluorescent labels.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 3, 2022
From: BIORA THERAPEUTICS, INC.
To: ENUMERA MOLECULAR, INC.
Reel/Frame 060092/0687 →
CHANGE OF NAME Recorded May 16, 2022
From: PROGENITY, INC.
To: BIORA THERAPEUTICS, INC.
Reel/Frame 060072/0817 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 22, 2021
From: SEKEDAT, MATTHEW; BUIS, JEFFREY; BEAUBIEN, RONALD DAVID; SINGH, SHARAT; PERRY, JEFF; LOCKTON, STEVEN; JAIN, CHANDNI; JAMESON-KIESLING, NATALIE MAE
To: PROGENITY, INC.
Reel/Frame 057557/0744 →
Continuity (7)
Continuation PCTUS2020026456 · Apr 2, 2020
Provisional Application 62913543 · Oct 10, 2019
Provisional Application 62913542 · Oct 10, 2019
Provisional Application 62910397 · Oct 3, 2019
Provisional Application 62910394 · Oct 3, 2019
Provisional Application 62828397 · Apr 2, 2019
Related Publication 20210164029A1 · Jun 3, 2021